Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0466988727858293 0.0628019323671498 0.0466988727858293 0.0628019323671498
Stock impact report

New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens

TETRAPHASE PHARMACEUTICALS INC (TTPH) 
Last tetraphase pharmaceuticals inc earnings: 3/11 09:29 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tphase.com/investor-relations
Company Research Source: Business Wire
­ Additional Data Points to Potential of XERAVA to Treat Carbapenem-Resistant, Multidrug-Resistant Escherichia Coli ­ ­TP-6076 Demonstrates In Vivo Efficacy in Murine Lung and Thigh Infection Models with Acinetobacter Baumannii­ WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on commercializing novel tetracyclines to treat serious and life-threatening conditions, announced the presentation of new data on XERAVA™ (eravacycline), a novel, fully synthetic fluorocycline approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of complicated intra-abdominal infections (cIAI) in adults, and TP-6076, a clinical-stage candidate targeting multidrug-resistant (MDR) infections, at the American Society for Microbiology (ASM) Microbe 2019 Annual Meeting held June 20-24 in San Francisco.“The data presented at ASM Microbe underscore the broad potential of XERAVA as a potent a Show less Read more
Impact Snapshot
Event Time:
TTPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TTPH alerts
Opt-in for
TTPH alerts

from News Quantified
Opt-in for
TTPH alerts

from News Quantified